# Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules

> **NCT04171492** · — · ACTIVE_NOT_RECRUITING · sponsor: **Biodesix, Inc.** · enrollment: 2000 (estimated)

## Conditions studied

- Nodule Solitary Pulmonary
- Non-small Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04171492
- **Lead sponsor:** Biodesix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-12-18
- **Primary completion:** 2025-12
- **Final completion:** 2026-12
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04171492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04171492, "Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04171492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*